Trial Profile
Phase I Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- Sponsors Protgen
- 18 Oct 2010 New trial record